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ABSTRACT 
 
RuII(6-p-cymene) complexes of two bidentate (O,O) alkoxycarbonylmethyl-3-hydroxy-
2(1H)-pyridone ligands exhibit in vitro antitumor activity. We determined their stoichiometry 
and stability in aqueous solution by pH-potentiometry, 1H NMR spectroscopy and UV-Vis 
spectrophotometry and also characterized the proton dissociation processes of the ligands. 
Formation of mono-ligand complexes with moderate stability was found to predominate in the 
physiological pH range. Moreover, the chlorido/aqua co-ligand exchange processes of the 
[RuII(6-p-cymene)(L)(H2O)]
+ species were also monitored and 55–65% of the aqua ligand 
was found to be replaced by chloride in 0.2 M KCl containing aqueous solutions. Under basic 
conditions, the complexes decompose to dinuclear tri-hydroxido-bridged [Ru(
6-p-
cymene)2(OH)3]
+ and metal-free ligand and also a hydroxido species [RuII(6-p-
cymene)(L)(OH)] was found. Furthermore, the ligands contain an ester functional group, 
which may hydrolyze at basic pH, which is however negligible at acidic or neutral pH.  
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1. Introduction 
 
Anticancer metallodrug research started with the discovery of cisplatin and its introduction to 
clinical practice almost four decades ago [1,2]. The main goal of the development of novel 
anticancer metal-based compounds is to increase their selectivity and therapeutic index and 
thereby overcome the adverse effects and resistance phenomena, which are a major limitation 
for the curative treatment of cancer. Ruthenium compounds are currently considered as the 
most promising candidates for the next generation of antitumor metal complexes [2−4]. Two 
representatives of this class of compounds have entered clinical trials so far, i.e., imidazolium 
trans-[tetrachlorido(dimethylsulfoxide)(1H-imidazole)ruthenate(III)] (NAMI-A) [5,6] and 
indazolium trans-[tetrachloridobis(1H-indazole)ruthenate(III)] (KP1019) [7,8]. The reduction 
of RuIII complexes to RuII in the more reductive tumor environment as compared to normal 
tissue is an important step of activation. In addition to RuIII coordination compounds, 
organometallic RuII complexes mainly with piano stool structure were developed and tested in 
vitro and in vivo. Among the RuII(arene) complexes a large number of [RuII(6-p-
cymene)(XY)Cl]-type compounds were prepared, where XY is an (O,O), (O,S), (O,N), (N,N) 
or (N,S) bidentate ligand [9−16]. The replacement of chlorido by aqua ligands can take place 
in aqueous solution, which is considered an essential step of activation [17−20]. However, the 
ultimate target of these organometallic RuII(arene) complexes is still not clear [21,22]. As 
other anticancer metallodrugs, they can be regarded as prodrugs and it is a prerequisite to 
follow their speciation in biological fluids for a better understanding of the pharmacokinetic 
properties and the mechanism of action. Aqueous solution equilibrium studies are a first 
approach to characterize possible dissociation reactions of such metal complexes in solution 
at low concentration. The displacement of original ligands by endogenous biomolecules 
strongly depends on the thermodynamic stability and kinetic inertness/lability. However, little 
is known about the stability of RuII(arene) complexes. Buglyó and co-workers determined 
stability data for RuII(6-p-cymene) complexes with bidentate (O,O) ligands [23,24], and also 
the pKa values of the coordinated water molecule in [Ru
II(6-p-cymene)(XY)(H2O)] species 
were reported [9,18,24,25]. Complexes bearing (O,O) bound hydroxypyrones show only 
moderate cytotoxicity and much lower stability as compared to (O,N) or (O,S) type complexes 
[26,27]. Switching from hydroxypyrones (such as the well-known maltol) to 
hydroxypyridones allows tuning the chelating ability and drug-like parameters, such as 
lipophilicity [18]. The Ru complex [RuII(6-p-cymene)(EHP)Cl] {EHP = N-
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[(ethoxycarbonyl)methyl]-3-hydroxy-2-(1H)-pyridone} was previously prepared and 
evaluated as an anticancer agent in CH1 adenocarcinoma human cells of the ovary, showing 
moderate cytotoxicity (IC50 240 M) [18]. 
In this work, the behavior of RuII(6-p-cymene) complexes of the 
alkoxycarbonylmethyl-3-hydroxy-2(1H)-pyridone ligands, i.e., EHP and N-
[(ethoxycarbonyl)methyl]-3-hydroxy-4-methyl-2-(1H)-pyridone (EHMP) (Chart 1) in 
aqueous solution was studied by pH-potentiometry, 1H NMR spectroscopy and UV-Vis 
spectrophotometry in order to determine the stoichiometry and stability of the complexes as 
well as the proton dissociation processes of the ligands.  
 
Chart 1 
 
 
2. Experimental 
 
2.1. Chemicals 
 
The ligands EHP and EHMP were prepared as described previously [18]. The purity and 
hydrolytic stability of the ligands was checked and the exact concentrations of the stock 
solutions were determined by the Gran method [28]. [RuII(6-p-cymene)Cl2]2 was synthesized 
and purified according to a literature procedure [29]. A stock solution of [RuII(6-p-cymene)] 
was obtained by dissolving a known amount of [RuII(6-p-cymene)Cl2]2 in water and the 
exact concentration was determined with pH-potentiometric titrations employing literature 
data for [RuII(6-p-cymene)]–hydroxido complexes [23].    
 
2.2. pH-potentiometric measurements 
 
The pH-potentiometric measurements for determination of the protonation constants of the 
ligands and the overall stability constants of the metal complexes were carried out at 25.0 ± 
0.1 °C in water and at an ionic strength of 0.20 M (KCl, Sigma-Aldrich) in order to keep the 
activity coefficients constant. The titrations were performed with carbonate-free KOH 
solution of known concentration (0.20 M). Both the base and the HCl used were Sigma-
Aldrich products and their concentrations were determined by pH-potentiometric titrations. 
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An Orion 710A pH-meter equipped with a Metrohm combined electrode (type 6.0234.100) 
and a Metrohm 665 Dosimat burette were used for the pH-potentiometric measurements. The 
electrode system was calibrated to the pH = −log[H+] scale by means of blank titrations 
(strong acid vs. strong base: HCl vs. KOH), as suggested by Irving et al. [30]. The average 
water ionization constant, pKw, was determined as 13.76 ± 0.01 at 25.0 °C, I = 0.20 M (KCl), 
which corresponds well to the literature [31]. The reproducibility of the titration points 
included in the calculations was within 0.005 pH. The pH-potentiometric titrations were 
performed in the pH range 2.0−11.5. The initial volume of the samples was 10.0 mL. The 
ligand concentration was 2 × 10–3 M and metal ion-to-ligand ratios of 1:1 to 1:4 were used. 
The accepted fitting of the titration curves was always less than 10 L. Samples were 
degassed by bubbling purified argon through them for ca. 10 min prior to the measurements 
and it was also passed over the solutions during the titrations. 
  For testing the hydrolytic stability of the ligands, stock solutions were prepared at 
various pH values (pH 1.83, 7.61 and 11.11) and titrations were performed at pH 1.83 after 
0.5, 47 and 191 h, at pH 7.61 after 1, 48 and 120 h and at pH 11.11 after 0.17, 0.33, 1.42, 
1.62, 2.7, 4, 24 and 188 h.  
The protonation constants of the ligands were determined with the computer program 
HYPERQUAD [32]; PSEQUAD [33] was utilized to establish the stoichiometry of the 
complexes and to calculate the stability constants. MpLqHr is defined for the general 
equilibrium pM + qL + rH  MpLqHr as (MpLqHr) = [MpLqHr]/[M]
p[L]q[H]r where M 
denotes a metal ion and L the completely deprotonated ligand. Literature log values of the 
[RuII(6-p-cymene)(hydroxido)] complexes were used [23] and compared to data collected in 
the course of the experiments described herein. In all calculations exclusively titration data 
were used from experiments in which no precipitate was visible in the reaction mixture. 
 
2.3. UV–Vis spectrophotometric and 1H NMR measurements 
 
A Hewlett Packard 8452A diode array spectrophotometer was used to record the UV-Vis 
spectra in the interval 200–800 nm. The path length was 1 cm. Protonation and stability 
constants and the individual spectra of the species were calculated with the computer program 
PSEQUAD [33]. The spectrophotometric titrations were performed on samples of the ligands 
alone or with [RuII(6-p-cymene)] over the pH range 2.0–11.5 at an ionic strength of 0.20 M 
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(KCl) and at 25.0 ± 0.2 °C. The concentration of ligands was set constant at 1 × 10–4 M and 
the metal-to-ligand ratios were 1:1 and 1:2.  
1H NMR studies were carried out on a Bruker Ultrashield 500 Plus instrument. 4,4-
Dimethyl-4-silapentane-1-sulfonic acid was used as an NMR standard. The ligands were 
dissolved in a 10% (v/v) D2O/H2O mixture to yield a concentration of 2−4 mM and were 
titrated at 25 °C, at I = 0.20 M (KCl) in absence or presence of [RuII(6-p-cymene)] at 1:1 and 
1:2 metal-to-ligand ratios. 1H NMR spectra were recorded to study the H2O/Cl
− exchange 
processes in the [RuII(6-p-cymene)(L)] complexes at pH 5.8 and 7.4 in dependence of the Cl− 
concentration (4−500 mM). 
 
2.4. Determination of the distribution coefficient (logD7.4) of EHP and EHMP 
 
LogD7.4 values of EHP and EHMP were determined by the traditional shake flask method 
[34] in n-octanol/HEPES-buffered aqueous solution at pH 7.4 (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid, HEPES) at 25.0 ± 0.2 °C. Two parallel experiments were 
performed for each sample. The ligands were dissolved at 0.10 mM in n-octanol pre-saturated 
aqueous solution of the buffer (10 mM) at constant ionic strength (0.20 M KCl). The aqueous 
solutions and n-octanol (1:1) were gently mixed with 360° vertical rotation for 2 h to avoid 
emulsion formation, and the mixtures were centrifuged at 5000 rpm for 3 min with a HeroLab 
centrifuge. After separation of the phases, UV spectra of the ligands in the aqueous phase 
were compared with those of the original aqueous solutions in the range 250–400 nm and 
logD7.4 values were calculated using equation 1. 
 
 log   .  = log  
                  	        
                 	     
− 1     (1) 
 
The absorbance was obtained at the region of lmax (~300 nm) ± 10 nm. The partition 
coefficients (logP) of EHP and EHMP were calculated using equation 2. 
 
log P = log (D × (1 + (Ka / [H
+])))      (2)   
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3. Results and discussion 
 
3.1. Proton dissociation processes and lipophilicity of the ligands 
 
The proton dissociation processes of the ligands EHP and EHMP (Chart 1) in water were 
followed by pH-potentiometry, UV spectrophotometry and 1H NMR titrations. The ligands 
contain ester functional groups and thus may undergo hydrolysis under acidic and basic 
conditions. Therefore, before studying the solution equilibria of the Ru complexes, a careful 
investigation of the hydrolytic stability of EHP and EHMP had to be performed. Stock 
solutions containing either ligand were prepared at pH 1.83, 7.61 and 11.11 and aliquots were 
titrated with the strong base KOH within a time frame of up to 191 h (Fig. S1). The formation 
of the carboxylic acid moiety by hydrolysis of the ester bond would result in extra base 
consumption and a shift of the equivalent point, which was only observed at pH 11.11. Within 
3 h ca. 45% of the ester had hydrolyzed, and remained constant during the rest of the 
experiment (Fig, S1.d). The hydrolytic stability of the ligands was also monitored by a second 
titration following re-acidification of the initially titrated aliquots of the acidic stock solution 
with the base. Overlapping consecutive titration curves were observed when the first titration 
was stopped at a maximum of pH ~10.4, demonstrating that no measurable ester hydrolysis of 
EHP and EHMP takes place between pH 2 and 10.4. In addition, the hydrolysis of EHP was 
monitored at pH 7.4 by 1H NMR spectroscopy (Fig. S2), which revealed that no measurable 
hydrolysis takes place at this pH value within 168 h. Based on these preliminary results, the 
proton dissociation constants (pKa) of the ligands were calculated from data collected in the 
pH range 2.0−10.4. The pKa values determined by the pH-potentiometric, UV and 
1H NMR 
titrations are collected in Table 1 and are in a fairly good agreement. The proton dissociation 
constants can be attributed to the deprotonation of the hydroxyl functional group. The pKa of 
EHP was found to be somewhat lower than that of the structurally related 3-hydroxy-1-
methylpyrid-2(1H)-one (MH2P, pKa = 8.89 [35]) due to the electron-withdrawing effect of the 
ester moiety. The presence of the neighboring electron-donating methyl group adjacent to the 
hydroxyl in EHMP results in higher basicity compared to EHP and MH2P. The 
deprotonation of EHP and EHMP is accompanied by characteristic changes of the ligand 
bands in the UV spectra (for EHP see Fig. 1). The development of new strong bands at a 
higher lmax value was observed for both ligands due to deprotonation which results in more 
extended conjugated  electron systems. The individual UV spectra of the ligand species (HL 
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and L–) were also calculated on basis of deconvolution of the pH-dependent spectra (Fig. S3 
and Table 1). The constant location of the isosbestic points in the spectra of the ligands (see 
Fig. 1 for EHP) also indicates that the ester hydrolysis is negligible in the pH range studied 
(pH 2.0–10.4).   
 
Table 1 
Fig. 1.     
 
 1H NMR spectroscopic titrations of the ligands gave very similar results (see Fig. 2 for 
EHP, Fig. S4 for EHMP). The chemical shifts (d) of the aromatic CH protons are sensitive to 
the protonation state of the ligands, and upfield shifts of these protons of EHP by increasing 
pH are as shown in Fig. 3. Based on these changes, the pKa values and chemical shifts of the 
individual ligand species (HL; L–) were calculated (Table 1). Above pH 10, signals were 
assigned to the hydrolysis products, i.e. the corresponding 3-hydroxy-2-oxopyridine-1(2H)-
carboxylate and ethanol (Fig. 2). 
 
Figs. 2, 3.     
 
Furthermore, EHP and EHMP were also characterized with regard to their 
lipophilicity and distribution coefficients at physiological pH (logD7.4), as determined via n-
octanol/water partitioning. The partition coefficients (logP) of the neutral, non-ionized species 
were calculated from the logD7.4 values using the proton dissociation constants (Table 1). 
EHMP exhibits a more lipophilic character than EHP due to the additional methyl group. 
 
3.2. Solution equilibria of [RuII(6-p-cymene)] complexes of EHP and EHMP 
 
The complex formation processes of the ligands with [RuII(6-p-cymene)(H2O)3]
2+ were 
studied by pH-potentiometry, UV-Vis spectrophotometry and 1H NMR spectroscopy in 
aqueous solution. The stability constants of the minor and major dinuclear hydrolysis products 
[Ru2(
6-p-cymene)2(OH)2]
2+ and [Ru2(
6-p-cymene)2(OH)3]
+, respectively, were determined 
by pH-potentiometry in the presence of 0.2 M KCl (Table 2) and were found to be in good 
agreement with data obtained by Buglyó and colleagues [23]. The chloride ion is considered 
as a non-innocent ligand for RuII [19,20,36], and thus these stability data are regarded as 
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conditional stability constants and are valid under the given conditions (0.2 M KCl, T = 25 
°C). The aqueous solution behavior of [RuII(6-p-cymene)] can be described well with the 
formation of the above mentioned three kinds of species at 0.2 M KCl ionic strength [23,24]. 
However various chlorido, hydroxido and mixed chlorido-hydroxido complexes are present at 
acidic pH, rather than [RuII(6-p-cymene)(H2O)3]
2+ and [Ru2(
6-p-cymene)2(OH)2]
2+ [36]. 
Above pH ~6.5 the dinuclear complex [Ru2(
6-p-cymene)2(
-OH)3]
+ predominates [23,36]. 
It was also found that the hydrolytic equilibria are reached quickly so that pH-potentiometric 
titrations can be employed to follow the process. 
The formation of the RuII(6-p-cymene) complexes with the ligands EHP and EHMP 
starts in the acidic pH range and the exclusive formation of mononuclear species with 1:1 
metal-to-ligand ratio was identified. Stability constants of the complexes [RuII(6-p-
cymene)(L)] were determined by pH-potentiometry and UV-Vis spectrophotometry 
monitoring complex formation via the changes of the charge transfer (CT) bands and they are 
in good agreement with each other (Table 2). In these complexes the bidentate (O,O) 
coordination mode of the ligands is the most feasible in solution, similarly to other 
hydroxypyridone compounds [37] as demonstrated by single-crystal X-ray diffraction studies 
[18]. Due to the slow ligand exchange processes observed in the 1H NMR spectra of the 
complexes with respect to the NMR time scale, the chemical shifts of the protons of the free 
and bound ligand and the RuII(6-p-cymene) moiety are clearly distinguishable (Figs. 4, 5, 
Fig. S5).  
 
Figs. 4, 5.     
 
The integrals of the pH-dependent proton peaks of the non-bound ligand and RuII(6-p-
cymene) moiety and the peaks of the metal complexes are proportional to the molar fractions 
of the species (Fig. 6). The molar fractions of the bound and free metal ions were also 
calculated on basis of the determined stability constants. Very good correlation between the 
pH-potentiometric and 1H NMR spectroscopic data were observed at pH < ca. 6. Up to this 
pH the formation of [RuII(6-p-cymene)(L)] reaches a maximum and good quality 1H NMR 
data was accessible (Fig. 4, Tables S1, S2). The aromatic ring protons of the ligands and all 
the protons of the RuII(6-p-cymene) moiety show significant electronic shielding effects as 
compared with the HL ligand forms and ligand-free organometallic arene moiety.  
 
10 
 
Fig. 6.     
The mono-ligand [RuII(6-p-cymene)(L)] species, in which L is a bidentate ligand,  
often bear a chlorido leaving group, as also shown in the solid state by X-ray diffraction 
analysis [9,18,38,39]. These compounds can undergo aquation of the chlorido ligand in 
aqueous solution. This exchange process usually takes place fast and is considered to be an 
important step for the biological activation of the metal complex [17−20]. The extent of the 
aquation strongly depends on the type of the bidentate ligand and the actual chloride 
concentration [17−20,36]. Therefore, the [RuII(6-p-cymene)(L)(H2O)]
+ + Cl−  [RuII(6-
p-cymene)(L)(Cl)] + H2O equilibria were studied for the bidentate (O,O) donor ligands EHP 
and EHMP using 1H NMR spectroscopy. Spectra were recorded at pH 5.8 where the mono-
ligand complexes predominate and at physiological pH (pH 7.4) using various chloride 
concentrations (Fig. S6). Fast ligand exchange processes were observed in the 1H NMR 
spectra as the signals of the aqua and chlorido species do not appear separately: A shift of the 
location of the cymene-CH peaks by about 0.1 ppm was observed by elevating the chloride 
concentration. A similar tendency was seen at both pH values studied (Fig. 7). Based on these 
spectral changes the equilibrium constants for the water/chloride exchange reactions were 
estimated (Table 2). The calculations should be considered only as estimations since a high 
excess of chloride (~ 0.5 M) was necessary to obtain saturation curves for the Ru complexes 
with a chlorido rather than an aqua ligand and thus the ionic strength of the solutions was not 
constant at 0.2 M. This effect was reached at a somewhat lower chloride concentration in the 
case of EHMP, and consequently a slightly higher logK’ value was obtained compared with 
EHP. According to these data about 38% and 55% of the EHP complex are chlorinated at 0.1 
and 0.2 M chloride concentration, respectively, while for EHMP approximately 48% and 
65% of the chlorinated species were found.   
 
Fig. 7.     
 
1H NMR titrations of the [RuII(6-p-cymene)]2+−ligand systems clearly revealed 
various overlapping processes above pH 6 (Fig. 5). When elevating the pH value, the mono-
ligand complex starts to dissociate resulting in the trihydroxido-bridged dinuclear species and 
the free ligand, which features a pH-dependent signal as its proton dissociation falls in this pH 
range. The dissociation of the [RuII(6-p-cymene)(L)] species is relatively slow and could not 
be followed by pH-potentiometry as the real equilibria could not be reached during the time-
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scale of this method (max. ~15 min at each point). This is a possible reason why the fit 
between the molar fractions calculated based on pH-potentiometry and 1H NMR 
spectroscopic data at pH > 6.5 is not satisfactory. In addition, the hydrolysis products of the 
ester bond cleavage of the ligand, i.e., the carboxylate and ethanol are also formed in solution 
at pH > ~9 (Fig. 5). Ester hydrolysis of the complexes occurs only at a slightly lower pH than 
for the ligands. Thus, no strong catalytic effect on the ligand hydrolysis of the metal ion is 
probable. According to this finding, the coordination via the carboxylate side chain after 
hydrolysis of the ester moiety is also not likely to occur at pH < 9. The hydrolytic stability of 
the [RuII(6-p-cymene)]2+−EHP ligand system was monitored at pH 7.40 by 1H NMR 
spectroscopy for a week and only ca. 5% hydrolysis product was observed.  
Besides the slow dissociation of the mono-ligand complex and the ester bond 
hydrolysis, a third process may be responsible for the significant shift of the 1H NMR signals 
of the mono-ligand complex at pH > 8. Most probably the formation of a mixed hydroxido 
species [RuII(6-p-cymene)(L)(OH)] takes place. Due to the above mentioned slow complex 
dissociation processes, no reliable stability constant could be calculated for this complex 
based on pH-potentiometric experiments. However, pKa values were estimated based on the 
pH-dependence of the signals of the CH(Ar) cymene protons in 1H NMR spectra (Fig. S7, 
Table 2). The pKa values of the mono complexes of EHP and EHMP are fairly similar and 
fall within the range found for half-sandwich RuII complexes with (O,O) coordinating ligands 
[9,14]. It is noteworthy that our data obtained in the presence of 0.2 M KCl are significantly 
higher as compared with the chloride-free medium [18], since the presence of competing 
chloride ions can suppress the hydrolysis of [RuII(6-p-cymene)(L)]. 
 
3.4. Comparison of the stability of [RuII(6-p-cymene)] complexes of EHP with EHMP and 
other related ligands 
 
Direct comparison of the stability constants of the [RuII(6-p-cymene)] complexes formed 
with the ligands EHP and EHMP (Table 2) reveals that the presence of the extra methyl 
group on the aromatic ring results in higher log values, although the pKa of EHMP is also 
higher. Therefore, the overall stability constants of the [RuII(6-p-cymene)(L)] species were 
corrected by the different ligand basicities according to the following competition reaction: 
 [RuII(6-p-cymene)]  + HL  [RuII(6-p-cymene)(L)] + H+   (3) 
 logK* = logβ [RuII(6-p-cymene)(L)] – pKa(HL)    (4) 
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A higher logK* implies more favored metal complex formation as compared with the 
protonated ligand. Based on these derived constants (logK* in Table 2), the electron donating 
methyl group adjacent to the coordination site in EHMP slightly increases the metal binding 
ability. The 3,4-hydroxypyridone deferiprone and maltol as a 3-hydroxy-4-pyrone feature 
similar structures as EHP and EHMP and the stability of their mono-ligand RuII(arene) 
complexes, which predominate at physiological pH in the mM concentration range are higher 
with logK* values of 2.08 and 0.61 reported for deferiprone and maltol, respectively [24]. 
Consequently, the stability order of the (O,O) chelates is the following: EHP < EHMP < 
maltol < deferiprone. These results fit the generally accepted stability trend, i.e., 3-
hydroxypyrid-4-ones > 3-hydroxypyrid-2-ones [35]. According to these results, it can be 
concluded that EHP and EHMP possess moderate binding ability towards [RuII(6-p-
cymene)] and significant dissociation of their complexes or the displacement of the original 
carrier ligand by other bioligands are probable under biologically relevant conditions, namely 
at low concentrations and at pH 7.4.     
 
 
4. Conclusions 
 
The two alkoxycarbonylmethyl-3-hydroxy-2(1H)-pyridones EHP and EHMP feature ethyl 
ester groups, which were found to be stable against hydrolysis in the pH range 2.0−10.4 in 
aqueous solution. The methylated derivative EHMP has higher basicity and lipophilicity. The 
stoichiometry and stability of their RuII(6-p-cymene) complexes were determined by pH-
potentiometry, 1H NMR spectroscopy and UV-Vis spectrophotometry in aqueous solution. 
Formation of mono-ligand complexes was found with moderate stabilities in which the 
ligands coordinate in a bidentate fashion via their oxygen donors. These species predominate 
in the physiological pH range at mM concentrations, but considerable dissociation and the 
partial displacement of the original ligands by endogenous competitors is possible. In 
addition, chlorido/aqua co-ligand exchange processes for the [RuII(6-p-cymene)(L)(H2O)]
+ 
species were monitored. Based on these data, it can be estimated that in the complex up to 55–
65% of the aqua ligand is replaced by chlorido at 0.2 M chloride concentration. The ester 
groups of the ligands in [RuII(6-p-cymene)(L)(H2O)]
+ show considerable hydrolysis only in 
the basic pH range where significant dissociation of the complex and formation of dinuclear 
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trihydroxido bridged [Ru2(
6-p-cymene)2(OH)3] and the hydroxido species [Ru
II(6-p-
cymene)(L)(OH)] was found.  
 
 
5. Abbreviations 
CT  charge transfer 
D  distribution coefficient 
EHP   N-[(ethoxycarbonyl)methyl]-3-hydroxy-2-(1H)-pyridone 
EHMP  N-[(ethoxycarbonyl)methyl]-3-hydroxy-4-methyl-2-(1H)-pyridone 
MH2P  3-hydroxy-1-methylpyrid-2(1H)-one 
P  partition coefficient 
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Table 1 
Proton dissociation constants (pKa) of EHP and EHMP with lmax, molar absorptivity (M
-1cm-
1) and calculated chemical shift (ppm) values for ligand species determined by UV 
spectrophotometric and 1H NMR titrations (T = 25.0 °C, I = 0.20 M (KCl)).a 
 EHP EHMP 
pKa (pH-potentiometry) 8.60(2) 9.20(3) 
pKa (UV) 8.58(1) 9.21(1) 
pKa (
1H NMR) 8.56(1) 9.19(1) 
logD7.4 −0.10(1) +0.64(2) 
logP −0.07 +0.65 
 HL L− HL L− 
λmax (nm) / 
ε (mol-1dm3cm-1) 
300 / 6156 
238 / 3227 
314 / 7485 
260 / 4935 
298 / 6881 
242 / 2616 
312 / 8718 
267 / 5427 
d / ppmb HL L− HL L− 
CH(4) (d) 7.179 6.767 − − 
CH3(4) (s) − − 2.187 2.087 
CH(5)c 6.440 6.313 7.112 6.725 
CH(6) (d) 7.086 6.562 6.403 6.316 
CH2 (q)
d 4.264 4.250 4.256 4.242 
CH3 (t)
d 1.271 1.271 1.266 1.266 
a Uncertainties (SD) are shown in parentheses for the species characterized in the 
present work. 
b The signal of -CH2C=O (s) lies underneath the water peak. 
c CH(5) EHP: (d/d), EHMP: (d) 
d Data of ethanol for comparison: CH2 (q) = 3.65 ppm; CH3 (t) = 1.17 ppm 
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Table 2 
Overall stability constants (log) with some stepwise and derived constants of the [RuII(6-p-
cymene)] complexes of EHP and EHMP (T = 25.0 °C, I = 0.20 M (KCl))a 
 EHP EHMP 
log ([RuII(6-p-cymene)(L)]) (pH-metry) 8.49(1) 9.33(1) 
log ([RuII(6-p-cymene)(L)]) (UV−Vis) 8.55(9) 9.30(1) 
pa ([Ru
II(6-p-cymene)(L)]) (1H NMR)b 9.39(1) 9.46(3) 
logK’ (H2O/Cl
−)c 0.78(2) 0.96(2) 
logK* d −0.11 +0.13 
a Uncertainties (SD) are shown in parentheses for the species 
characterized in the present work. Hydrolysis products of the metal ion: 
log [Ru2(
6-p-cymene)2H−2]
2+ = −7.01(1) and log [(Ru2(
6-p-
cymene)2H−3]
+ = −11.99(1). 
b [RuII(6-p-cymene)(L)]  [RuII(6-p-cymene)(L)(OH)] + H+ 
c [RuII(6-p-cymene)(L)(H2O)]
+ + Cl−  [RuII(6-p-cymene)(L)(Cl)] + 
H2O 
d logK* = logβ [RuII(6-p-cymene)(L)] – pKa(HL)
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Chart 1. Ligands used in this study: EHP = N-[(ethoxycarbonyl)methyl]-3-hydroxy-2-(1H)-
pyridone; EHMP = N-[(ethoxycarbonyl)methyl]-3-hydroxy-4-methyl-2-(1H)-pyridone  
 
 
 
 
Fig. 1. UV absorbance spectra of ligand EHMP recorded in the pH range of 2.0−10.3 (cEHP = 
0.1 mM; T = 25.0 °C; I = 0.20 M (KCl)). 
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Fig. 2. Low (a) and high (b) field regions of the 1H NMR spectra of EHP recorded at the 
indicated pH values (cEHP = 4 mM; T = 25.0 °C; I = 0.20 M (KCl); 10% D2O). The peaks 
stemming from the hydrolysis products 3-hydroxy-2-oxopyridine-1(2H)-carboxylate (on a) 
and ethanol (on b) are annotated with stars.  
 
 
 
 
 
Fig. 3. pH-Dependence of the chemical shifts (d) of the EHP protons: CH(4) (×); CH(6) (■); 
CH(5) (○) (T = 25.0 °C; I = 0.20 M (KCl); 10% D2O). 
 
  
CH(4) CH(6) CH(5) CH3
d / ppm
7.6       7.3        7.0        6.7        6.4    6.2       1.34           1.28            1.22            1.16   
(a) (b)
*
*
*
*
* *
**
6.2
6.4
6.6
6.8
7.0
7.2
2 4 6 8 10 12
d
/ 
p
p
m
pH
20 
 
 
Fig. 4. 1H NMR spectrum of the [RuII(6-p-cymene)]–EHP system recorded at pH 6.09. The 
peaks with the grey background correspond to non-bound ligand and metal ion (cEHP = 2 mM; 
M:L = 1:1; T = 25.0 °C, I = 0.20 M (KCl), 10% D2O).  
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Fig. 5. Representative 1H NMR spectra of the [RuII(6-p-cymene)]–EHP system recorded at 
various pH values (cEHP = 2 mM; M:L = 1:1; T = 25.0 °C, I = 0.20 M (KCl), 10% D2O). 
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Fig. 6. Bound and ligand-free metal ion fractions for the [RuII(6-p-cymene)]–EHP (a) and –
EHMP (b) systems calculated on the basis of the stability constants of the [RuII(6-p-
cymene)(L)] species (solid lines) and 1H NMR peak integrals of the singlet CH3 (cymene 
moiety) protons: bound (●), free (×) fractions. Errors are calculated with the help of the ligand 
distribution on basis of the ligand peaks in the NMR spectra (cligand = 2 mM; M:L = 1:1; T = 
25.0 °C, I = 0.20 M (KCl), 10% D2O). 
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Fig. 7. 1H NMR chemical shifts (d) of the CH(6) and CH(5) peaks of the [RuII(6-p-
cymene)(L)]+ complexes of EHP (black) and EHMP (grey), respectively, plotted against the 
chloride concentration at pH 5.8 (○) and 7.4 (×) together with the fitted curves (cligand = 2 
mM; M:L = 1:1; T = 25.0 °C, 10% D2O). 
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